10.1002/jcb.30503 7 BeheraL
John Barlow has sat on advisory board panels and received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Mylan, Novartis and Sanofi/Aventis
Serious side effects are rare but include signs of pancreatitis (severe abdominal pain), thyroid changes, and gallbladder issues
The peptide strengthens the intestinal barrier, reducing gut permeability and protecting against leaky gut
reported higher odds of GI adverse events with semaglutide followed by liraglutide and dulaglutide [11]
One caveat that matters for anyone with existing skin conditions: patches applied over eczema, psoriasis, or broken skin can worsen those conditions and, paradoxically, increase absorption of whatever botanical compounds are present